R01 CA151532/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2012	3
2013	9
2014	1
2016	2
2017	3
2018	1
2024	0

1

Targeted therapies in neuroendocrine tumors (NET): clinical trial challenges and lessons learned.

Yao JC, Lagunes DR, Kulke MH. Yao JC, et al. Oncologist. 2013;18(5):525-32. doi: 10.1634/theoncologist.2012-0434. Epub 2013 Apr 24. Oncologist. 2013. PMID: 23615698 Free PMC article. Review.

2

Consensus guidelines for the management and treatment of neuroendocrine tumors.

Kunz PL, Reidy-Lagunes D, Anthony LB, Bertino EM, Brendtro K, Chan JA, Chen H, Jensen RT, Kim MK, Klimstra DS, Kulke MH, Liu EH, Metz DC, Phan AT, Sippel RS, Strosberg JR, Yao JC; North American Neuroendocrine Tumor Society. Kunz PL, et al. Pancreas. 2013 May;42(4):557-77. doi: 10.1097/MPA.0b013e31828e34a4. Pancreas. 2013. PMID: 23591432 Free PMC article.

3

Characterization of the Neuroendocrine Tumor Immune Microenvironment.

da Silva A, Bowden M, Zhang S, Masugi Y, Thorner AR, Herbert ZT, Zhou CW, Brais L, Chan JA, Hodi FS, Rodig S, Ogino S, Kulke MH. da Silva A, et al. Pancreas. 2018 Oct;47(9):1123-1129. doi: 10.1097/MPA.0000000000001150. Pancreas. 2018. PMID: 30153220 Free PMC article.

4

Are neuroendocrine tumors going mainstream?

Kulke MH. Kulke MH. J Clin Oncol. 2013 Feb 1;31(4):404-5. doi: 10.1200/JCO.2012.47.3884. Epub 2012 Dec 17. J Clin Oncol. 2013. PMID: 23248246 No abstract available.

5

Systemic therapy for advanced pancreatic neuroendocrine tumors.

Kulke MH. Kulke MH. Semin Oncol. 2013 Feb;40(1):75-83. doi: 10.1053/j.seminoncol.2012.11.010. Semin Oncol. 2013. PMID: 23391115 Free PMC article. Review.

6

Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma.

Bowden M, Zhou CW, Zhang S, Brais L, Rossi A, Naudin L, Thiagalingam A, Sicinska E, Kulke MH. Bowden M, et al. Oncotarget. 2017 Apr 7;8(33):54331-54344. doi: 10.18632/oncotarget.16908. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903345 Free PMC article.

7

Association Between Tumor Progression Endpoints and Overall Survival in Patients with Advanced Neuroendocrine Tumors.

Ter-Minassian M, Zhang S, Brooks NV, Brais LK, Chan JA, Christiani DC, Lin X, Gabriel S, Dinet J, Kulke MH. Ter-Minassian M, et al. Oncologist. 2017 Feb;22(2):165-172. doi: 10.1634/theoncologist.2016-0175. Epub 2017 Feb 8. Oncologist. 2017. PMID: 28179574 Free PMC article.

8

Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.

Roy R, Zurakowski D, Wischhusen J, Frauenhoffer C, Hooshmand S, Kulke M, Moses MA. Roy R, et al. Br J Cancer. 2014 Oct 28;111(9):1772-9. doi: 10.1038/bjc.2014.462. Epub 2014 Aug 19. Br J Cancer. 2014. PMID: 25137018 Free PMC article.

9

Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors.

Chan JA, Stuart K, Earle CC, Clark JW, Bhargava P, Miksad R, Blaszkowsky L, Enzinger PC, Meyerhardt JA, Zheng H, Fuchs CS, Kulke MH. Chan JA, et al. J Clin Oncol. 2012 Aug 20;30(24):2963-8. doi: 10.1200/JCO.2011.40.3147. Epub 2012 Jul 9. J Clin Oncol. 2012. PMID: 22778320 Free PMC article. Clinical Trial.

10

Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumors.

Chan JA, Ryan DP, Zhu AX, Abrams TA, Wolpin BM, Malinowski P, Regan EM, Fuchs CS, Kulke MH. Chan JA, et al. Endocr Relat Cancer. 2012 Sep 14;19(5):615-23. doi: 10.1530/ERC-11-0382. Print 2012 Oct. Endocr Relat Cancer. 2012. PMID: 22736724 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

18 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year